GLP3 30mg – Research Grade

Research-grade compound supplied by Ivarah Labs.

Ingredients Per Vial

Total Content: 30mg

Package Contents: 1 × 30mg Lyophilized Powder Vial

GLP3 30mg

Ivarah Labs GLP3 30mg is manufactured for laboratory research applications requiring consistency, purity, and reliable handling. Each vial is supplied as a sterile lyophilized research preparation and produced under controlled quality standards to support advanced scientific investigations.

GLP3 (LY3437943) is an investigational synthetic peptide designed as a triple receptor agonist that activates the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. Its unique multi-receptor activity has made GLP3 an important compound for researchers investigating metabolic regulation, receptor pharmacology, endocrine physiology, and peptide signaling pathways.

Published Scientific Research

GLP3 has been evaluated in multiple clinical research programs investigating obesity, metabolic disease, glucose regulation, and cardiometabolic health. In a randomized Phase 2 clinical trial published in the New England Journal of Medicine, investigators reported substantial dose-dependent reductions in body weight over a 48-week treatment period among adults with obesity or overweight. The study demonstrated promising efficacy while continuing to evaluate long-term safety and tolerability in controlled research settings.

The compound has progressed into the international TRIUMPH Phase 3 clinical development program, which continues to investigate GLP3 across multiple patient populations, including obesity, overweight with type 2 diabetes, and obesity associated with cardiovascular risk factors. These studies are designed to further characterize efficacy, safety, pharmacokinetics, and long-term clinical outcomes.

Mechanism of Action

Unlike single-receptor peptide agonists, GLP3 simultaneously activates three distinct receptors involved in metabolic regulation:

• GLP-1 Receptor – Investigated for its role in appetite regulation, glucose metabolism, and insulin secretion.
• GIP Receptor – Studied for effects on insulin response, nutrient utilization, and metabolic signaling.
• Glucagon Receptor – Evaluated for its influence on energy expenditure, lipid metabolism, and hepatic glucose regulation.

The coordinated activation of these receptor systems has made GLP3 one of the most extensively studied investigational peptides in modern metabolic research.

Research Applications

Researchers frequently utilize GLP3 in laboratory investigations involving:

• Triple receptor agonist pharmacology
• Peptide receptor signaling pathways
• Metabolic regulation research
• Energy homeostasis
• Obesity and adipose tissue research
• Endocrine physiology
• Glucose metabolism
• Insulin signaling
• Cardiometabolic biomarkers
• Molecular biology and peptide characterization

Product Specifications

• 30mg GLP3
• Lyophilized Powder Format
• Sterile Research Vial
• High-Purity Research Grade
• Third-Party Tested for Quality Verification
• Manufactured Under Controlled Quality Standards
• Tamper-Resistant Packaging
• Suitable for Laboratory Research Applications
• For Research Use Only

Storage

Store according to established laboratory handling procedures. Protect from excessive heat, moisture, freezing, and direct sunlight. After reconstitution, store according to the research protocol and maintain appropriate laboratory conditions.

Quality Assurance

Ivarah Labs is committed to transparency, consistency, and research quality. Every production batch undergoes established quality control procedures designed to support reliable laboratory investigations. Certificates of Analysis (COAs) are provided when available to verify batch-specific analytical results.

Research Use Only